Association between ankylosing spondylitis and m6A methylation

J Orthop Surg Res. 2023 Oct 7;18(1):757. doi: 10.1186/s13018-023-04254-x.

Abstract

Background: N6-methyl adenosine (m6A) is the most common reversible mRNA modification in eukaryotes implicated in key roles in various biological processes. The purpose of our analysis was to examine the association of ankylosing spondylitis (AS) with m6A methylation.

Method: We obtained 72 samples from the data set GSE73754, including 52 AS patients and 20 healthy people. We divided the samples into two groups: the experimental group and the control group, and then observed the differences of 26 m6A related genes in the two groups. We also analyzed the correlation between different m6A genes. We used a random forest tree model to screen seven m6A signature genes associated with AS to evaluate its prevalence. Next, the samples were classified according to the m6a content and differential genes. Immune analysis, gene ontology, and KEGG enrichment analyses were performed. Finally, we scored each sample with m6a and analyzed the relationship between different samples and inflammation-related factors.

Results and conclusion: In conclusion, we screened out AS-related genes and the nomogram showed that they were negatively correlated with the incidence of AS. And we found that AS may have some relationship with immunity. Our analysis results could provide further insights into the treatment of AS.

Keywords: Ankylosing spondylitis; Bioinformatics; N6-methyladenosine.

MeSH terms

  • Adenosine / genetics
  • Gene Ontology
  • Humans
  • Inflammation
  • Methylation
  • Spondylitis, Ankylosing* / epidemiology
  • Spondylitis, Ankylosing* / genetics

Substances

  • Adenosine